Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma
临床医生和管理人员对复发或难治性多发性骨髓瘤门诊使用ciltacabtagene autoleucel的看法
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1405452
Hansen, Doris K; Dhakal, Binod; Hamadani, Mehdi; Dingli, David; Jain, Tania; Huff, Carol Ann; Janakiram, Murali; Liu, Yi-Hsuan; De Braganca, Kevin C; Lodowski, Nicole; Sander, Jennifer; Okorozo, Peter; McFarland, Lindsay; Perciavalle, Matthew; Huo, Stephen; Qureshi, Zaina P; Patel, Krina K